Understanding nanoparticle-liver interactions in nanomedicine

Area of Science:

• Nanomedicine
• Hepatology
• Biomaterials Science

Background:

• The liver's phagocytic Kupffer cells sequester up to 99% of administered nanoparticles.
• This significant accumulation impacts nanomedicine safety, efficacy, and clinical translation.

Purpose of the Study:

• To review recent findings on nanoparticle-liver interactions.
• To explore strategies for enhancing nanomedicine delivery to the liver.
• To discuss the influence of aging on liver phagocytic function and nanomedicine efficacy.

Main Methods:

• Literature review of recent studies on nanoparticle-liver interactions.
• Analysis of physicochemical properties influencing nanoparticle biodistribution.
• Examination of Kupffer cell modulation strategies for targeted delivery.

Main Results:

• Nanoparticle physicochemical properties significantly affect liver uptake and distribution.
• Modulating Kupffer cells can enhance targeted nanoparticle delivery for hepatic disease treatment.
• Aging alters liver phagocytic capacity, influencing nanoparticle interactions.

Conclusions:

• Understanding nanoparticle-liver dynamics is crucial for developing effective nanomedicines.
• Liver accumulation presents both challenges and opportunities for therapeutic applications.
• Further research into aging effects is needed for optimized nanomedicine design.